- Gaucher or pseudo‑Gaucher cells
-
Kaur G, Ahuja A, Vishwananthan G, Sen A
- KMID: 2562546
- Blood Res.
- 2024;59:7.
- doi: 10.1007/s44313-024-00005-x
-
- CITED
-
- Close
- SHARE
-
- Close
- Correction: MicroRNA‑765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
-
Kang S, Choi J
- KMID: 2562524
- Blood Res.
- 2024;59:20.
- doi: 10.1007/s44313-024-00020-y
-
- CITED
-
- Close
- SHARE
-
- Close
- Correction: Abnormal frequency of the memory B cell subsets and plasmablasts in patients with congenital severe hemophilia A: correlation with “Inhibitor” formation
-
Zekavat O, Movahednezhad Y, Shahsavani A, Haghpanah S, Shokrgozar N, Golmoghaddam H, Kalani M, Bordbar M, Arandi N
- KMID: 2562521
- Blood Res.
- 2024;59:17.
- doi: 10.1007/s44313-024-00019-5
-
- CITED
-
- Close
- SHARE
-
- Close
- Peripheral T‑cell lymphoma, NOS in bone marrow and heart
-
Lee H, Lee J
- KMID: 2552887
- Blood Res.
- 2024;59:5.
- doi: 10.1007/s44313-024-00009-7
-
- CITED
-
- Close
- SHARE
-
- Close
- Comparative efficacy of VMP vs. Rd in newly diagnosed, autologous stem cell transplant‑ineligible multiple myeloma patients: a prematurely terminated randomized controlled study, CAREMM‑2002 study
-
Huh C, Park S, Lee J, Min C, the Catholic Research Network for Multiple Myeloma (CAREMM-2002 study)
- KMID: 2562528
- Blood Res.
- 2024;59:24.
- doi: 10.1007/s44313-024-00025-7
-
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative consultation for determining the appropriate transfusion strategy
-
Kang K
- KMID: 2562525
- Blood Res.
- 2024;59:21.
- doi: 10.1007/s44313-024-00021-x
Surgical patients are at risk of postoperative complications and mortality, necessitating preoperative patient optimiza‑ tion through the identification and correction of modifiable risk factors. Although preoperative platelet transfusions aim to reduce the risk of bleeding, their efficacy remains uncertain. Similarly,... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment with ropeginterferon alfa‑2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one‑year results from a phase 2 study
-
Yoon S, Lee S
- KMID: 2562527
- Blood Res.
- 2024;59:23.
- doi: 10.1007/s44313-024-00026-6
-
- CITED
-
- Close
- SHARE
-
- Close
- Acute erythroid leukemia leading to the diagnosis of Schwachman‑Diamond syndrome
-
Strasser B, Mustafa S, Tomasits J, Haushofer A
- KMID: 2562514
- Blood Res.
- 2024;59:10.
- doi: 10.1007/s44313-024-00008-8
-
- CITED
-
- Close
- SHARE
-
- Close
- Rare pseudo‑chediak‑higashi inclusions in a patient with disseminated diffuse large B cell lymphoma
-
Yan C, Fang Z, Liu J
- KMID: 2562517
- Blood Res.
- 2024;59:13.
- doi: 10.1007/s44313-024-00013-x
-
- CITED
-
- Close
- SHARE
-
- Close
- Transfusion‑transmitted infections
-
Kim H, Ko D
- KMID: 2562518
- Blood Res.
- 2024;59:14.
- doi: 10.1007/s44313-024-00014-w
The risk of transfusion-transmitted infection (TTI) has always existed because transfused blood products are biologi‑ cal materials derived from humans. To prevent TTIs, screening strategies have been developed for various infectious diseases, such as hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
- How to improve AML outcomes?
-
Tan T, Bozdag S
- KMID: 2562541
- Blood Res.
- 2024;59:39.
- doi: 10.1007/s44313-024-00041-7
Understanding the intricacies of the pathophysiology and genomic landscape has enhanced the long-term outcomes for patients with acute myeloid leukemia (AML). The identification of novel molecular targets has introduced new therapeutic strategies that attempt to surpass the dominance of the "7 + 3 regimen" established... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of next‑generation sequencing in hematologic malignancies
-
Cho Y
- KMID: 2562515
- Blood Res.
- 2024;59:11.
- doi: 10.1007/s44313-024-00010-0
Next-generation sequencing (NGS) allows high-throughput detection of molecular changes in tumors. Over the past 15 years, NGS has rapidly evolved from a promising research tool to a core component of the clinical labo‑ ratory. Sequencing of tumor cells provides an important step in detecting somatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Functional iron deficiency anemia in patients with cancer
-
Koh J, Song I
- KMID: 2562530
- Blood Res.
- 2024;59:26.
- doi: 10.1007/s44313-024-00030-w
Anemia is frequently observed in patients with cancer owing to anticancer chemotherapy, radiation therapy, and inflammatory responses. This often leads to functional iron deficiency, characterized by adequate iron stores but impaired use of iron for red blood cell production. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic testing for germline predisposition to hematologic malignancies
-
Hwang S
- KMID: 2562516
- Blood Res.
- 2024;59:12.
- doi: 10.1007/s44313-024-00012-y
Germline predisposition (GPD) to hematological malignancies has gained interest because of the increased use of genetic testing in this field. Recent studies have suggested that GPD is underrecognized and requires appropriate genomic testing for an accurate diagnosis. Identification of GPD significantly affects... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic technologies for detecting structural variations in hematologic malignancies
-
Jang M
- KMID: 2552886
- Blood Res.
- 2024;59:1.
- doi: 10.1007/s44313-024-00001-1
Genomic structural variations in myeloid, lymphoid, and plasma cell neoplasms can provide key diagnostic, prog‑ nostic, and therapeutic information while elucidating the underlying disease biology. Several molecular diagnostic approaches play a central role in evaluating hematological malignancies.... -
- CITED
-
- Close
- SHARE
-
- Close
- Absence of canonical mutations in pediatric essential thrombocytosis: a case series
-
Lee J, Jo S, Yoo J, Kim S, Chung N, Cho B
- KMID: 2562536
- Blood Res.
- 2024;59:32.
- doi: 10.1007/s44313-024-00036-4
Essential thrombocytosis (ET) is a rare myeloproliferative disease in children, and there are few standard man‑ agement guidelines. We herein report a case series of 10 pediatric patients with ET diagnosed at our institution over a period of 13 years. All patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Proper application of anticoagulation therapy on cancer‑associated venous thrombosis
-
Yhim H
- KMID: 2562529
- Blood Res.
- 2024;59:25.
- doi: 10.1007/s44313-024-00029-3
Cancer-associated venous thromboembolism (VTE) significantly impacts morbidity and mortality. The introduction of direct oral anticoagulants over the past decade has revolutionized VTE treatment in patients with active cancer, offering potential advantages over traditional therapies. However, uncertainties persist regarding the optimal... -
- CITED
-
- Close
- SHARE
-
- Close
- Monoclonal gammopathy of renal significance from the perspective of nephrologists
-
Park K, Kwon S
- KMID: 2562532
- Blood Res.
- 2024;59:28.
- doi: 10.1007/s44313-024-00027-5
Kidney disease is a frequent complication of multiple myeloma and other malignancies associated with monoclonal gammopathies. Additionally, dysproteinemia-related kidney disease can occur independently of overt multiple myeloma or hematologic malignancies. Monoclonal gammopathy of renal significance (MGRS) is a spectrum of disorders... -
- CITED
-
- Close
- SHARE
-
- Close
- Advancements in the understanding and management of histiocytic neoplasms
-
Koh K, Yoon S, Kang S, Kim H, Im H
- KMID: 2562526
- Blood Res.
- 2024;59:22.
- doi: 10.1007/s44313-024-00022-w
Histiocytic neoplasms are rare diseases involving macrophages, dendritic cells, and monocytes. They include Langer‑ hans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), Rosai-Dorfman disease (RDD), juvenile xanthogranuloma (JXG), and histiocytic sarcoma. Histiocytic neoplasms... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of lnc‑FOXD2‑AS1, CDC45, and CDK1 in patients with primary non‑M3 AML is associated with a worse prognosis
-
Manoochehrabadi S, Talebi M, Pashaiefar H, Ghafouri‑Fard S, Vaezi M, Omrani M, Ahmadvand M
- KMID: 2552883
- Blood Res.
- 2024;59:4.
- doi: 10.1007/s44313-024-00002-0
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with an unfavorable outcome. The present research aimed to identify novel biological targets for AML diagnosis and treatment. In this study, we per‑ formed an in-silico method to identify antisense... -
- CITED
-
- Close
- SHARE
-
- Close
